Merck to buy Schering-Plough for $41bnMerck & Company said on Monday that it would acquire Schering-Plough Corp for $41.1 billion, uniting the makers of cholesterol drugs Zetia and Vytorin in the second megadeal for Big Pharma in weeks. The two New Jersey-based drugmakers, More… |
SP fertility drug meets study goalsSchering-Plough Corporation, a worldwide research-based pharmaceutical company, on Tuesday said its experimental treatment for infertility, a follicle stimulant called corifollitropin alfa, met its main goals in a late-stage study. The dat More… |